The Impact of HIV/AIDS on Human Capital Investment in Sub-Saharan Africa: New Evidence

Chicoine, Luke and Lyons, Emily and Sahue, Alexia (2020): The Impact of HIV/AIDS on Human Capital Investment in Sub-Saharan Africa: New Evidence.

Abstract

The risk of AIDS-related mortality increased dramatically throughout the 1990s. This paper updates previous work by Fortson (2011) to examine the impact of mortality risk on human capital investment during the deadliest period of the pandemic. We combine Demographic Health Survey data from 30 countries, across 60 survey waves, to generate a sample of over 1,300,000 observations. Cohort-specific analysis using the updated sample yields new evidence that the negative relationship between HIV prevalence and schooling steepened as mortality risk increased. The reduction in schooling is largest for women, and along the extensive margin of the schooling decision. The findings indicate that the decline in human capital investment associated with the HIV/AIDS pandemic prior to the availability of treatment was larger in magnitude than previously understood, but may be reversing rapidly as access to treatment is expanded.

• Item Type: MPRA Paper
• Language: English
• Keywords: HIV/AIDS; mortality risk; schooling
• Subjects: I - Health, Education, and Welfare > I1 - Health > I15 - Health and Economic Development; I - Health, Education, and Welfare > I2 - Education and Research Institutions > I25 - Education and Economic Development; O - Economic Development, Innovation, Technological Change, and Growth > O5 - Economywide Country Studies > O55 - Africa

References

Baranov V, Bennett D, Kohler HP. 2015. The Indirect Impact of Antiretroviral Therapy: Mortality Risk, Mental Health, and HIV-negative Labor Supply. Journal of Health Economics 44: 195–211.

Baranov V, Kohler HP. 2018. The Impact of AIDS Treatment on Savings and Human Capital Investment in Malawi. American Economic Journal: Applied Economics 10: 266–306.

Bertrand M, Duflo E, Mullainathan S. 2004. How Much Should We Trust Differences-In-Differences Estimates? Quarterly Journal of Economics 119: 249–275.

Bor J, Herbst AJ, Newell ML, Bärnighausen T. 2013. Increases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-up of HIV Treatment. Science 339: 961–965.

Burke M, Gong E, Jones K. 2014. Income Shocks and HIV in Africa. Economic Journal 125: 1157–1189.

Chicoine L. 2012. AIDS Mortality and Its Effect on the Labor Market: Evidence from South Africa. Journal of Development Economics 98: 256–269.

Evans DK, Miguel E. 2007. Orphans and Schooling in Africa: A Longitudinal Analysis. Demography 44: 35–57.

Fortson JG. 2008. The Gradient in Sub-Saharan Africa: Socioeconomic Status and HIV/AIDS. Demography 45: 303–322.

Fortson JG. 2011. Mortality Risk and Human Capital Investment: The Impact of HIV/AIDS in Sub-Saharan Africa. Review of Economics and Statistics 93: 1–15.

Friedman WH. 2018. Antiretroviral Drug Access and Behavior Change. Journal of Development Economics 135: 392–411.

Global Burden of Disease Collaborative Network. 2018. Global Burden of Disease Study 2017 (GBD 2017) Covariates 1980-2017. University of Washington: Institute for Health Metrics and Evaluation (IHME).

Godlonton S, Thornton RL. 2013. Learning from Others’ HIV Testing: Updating Beliefs and Responding to Risk. American Economic Review 103: 439–44.

Gong E. 2014. HIV Testing and Risky Sexual Behaviour. Economic Journal 125: 32–60.

Haacker M. 2016. The Economics of the Global Response to HIV/AIDS. Oxford University Press.

Institute for Health Metrics and Evaluation (IHME). 2015. HIV Worldwide 1990-2013. Seattle, WA: IHME, University of Washington. Available from http://vizhub.healthdata.org/hiv (Accessed 2/11/20).

Jayachandran S, Lleras-Muney A. 2009. Life Expectancy and Human Capital Investments: Evidence from Maternal Mortality Declines. Quarterly Journal of Economics 124: 349–397.

Levinsohn J, McLaren ZM, Shisana O, Zuma K. 2013. HIV Status and Labor Market Participation in South Africa. Review of Economics and Statistics 95: 98–108.

Lucas AM, Chidothe M, Wilson NL. 2019. Effects of Adult Health Interventions at Scale on Children’s Schooling: Evidence from Antiretroviral Therapy in Zambia. Economics of Education Review 72: 107– 120.

Lucas AM, Wilson NL. 2013. Adult Antiretroviral Therapy and Child Health: Evidence from Scale-up in Zambia. American Economic Review 103: 456–61.

Murray CJ, Callender CS, Kulikoff XR, Srinivasan V, Abate D, Abate KH, Abay SM, Abbasi N, Abbastabar H, Abdela J, et al. 2018. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet 392: 1995–2051.

Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, et al. 2018. Global, Regional, and National Age-sex-specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet 392: 1736–1788.

Thirumurthy H, Graff Zivin J. 2012. Health and Labor Supply in the Context of HIV/AIDS: The Long-run Economic Impacts of Antiretroviral Therapy. Economic Development and Cultural Change 61: 73–96.

Tompsett A. 2020. The lazarus drug: The impact of antiretroviral therapy on economic growth. Journal of Development Economics 143: 102409.

World Bank. 2020. World Development Indicators. Washington, D.C. Available from http://wdi.worldbank.org (Accessed 2/11/20).